Since its founding in 1989, the company has been dedicated to the promise of cellular therapy and the goal of making cellular therapy a greater reality for more patients.
Miltenyi Biotec has more than 1,400 employees in 25 countries and a portfolio of more than 3,000 products.
Miltenyi Biotec offers instruments, tools and reagents to facilitate standardized and effective sample preparation.
With a market share of 70%, Miltenyi Biotec is the leader in the field of magnetic cell separation.
MACS Technology is used to isolate cells from blood, bone marrow or dissociated tissue according to specific surface markers.
Es kommt zu Niederschlagsmengen von 0 l/m², die Niederschlagswahrscheinlichkeit beträgt 13%, die Luftfeuchtigkeit 79%.
Übermorgen werden in Bergisch Gladbach Höchsttemperaturen von 7° (gefühlt: 5°) und schwacher Wind (13 km/h) aus Ostsüdost mit frischen Böen (35 km/h) erwartet.
Cell separation technology based on super paramagnetic beads was invented by the company founder, Stefan Miltenyi, in 1989 and enables the separation of any cell type using antibodies bound to magnetic beads.
The company has since developed a wide variety of reagents and devices optimized for manual and automated cell separation procedures, the lab bench, and clinical research.
Services offered by Miltenyi Biotec include gene expression analysis and contract production of biologicals according to GMP guidelines.
Miltenyi Biotec technologies are used in applications concerned with accessing, analyzing, and utilizing primary and primary-derived cells – across basic research, translational research, and clinical applications.
MACS Sample Preparation gentle MACS Dissociators MACS Cell Separation auto MACS Pro Separator MACS Flow Cytometry MACSQuant Analyzers MACS Antibodies MACSmolecular Clini MACS System MACS Cell Culture MACS Media MACS Cytokines Thera Sorb Viscover Imaging Agents Miltenyi Biotec is a global biotechnology company headquartered near Cologne in Bergisch Gladbach, Germany.